New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Therapeutic and diagnostic functions of one antibody for pancreatic cancer

Therapeutic and diagnostic functions of one antibody for pancreatic cancer

by Osaka UniversityFig.1: DKK1–CKAP4 signaling and application of the anti-CKAP4 antibody. DKK1 and CKAP4 are overexpressed in cancer cells and the PI3 kinase–AKT pathway is activated, promoting
Oncology May 20,2024
Therapeutic and diagnostic functions of one antibody for pancreatic cancer

Therapeutic and diagnostic functions of one antibody for pancreatic cancer

by Osaka UniversityFig.1: DKK1–CKAP4 signaling and application of the anti-CKAP4 antibody. DKK1 and CKAP4 are overexpressed in cancer cells and the PI3 kinase–AKT pathway is activated, promoting
Oncology May 20,2024
A rare disease inspires a new way to attack cancer

A rare disease inspires a new way to attack cancer

by Nathan Collins,Stanford UniversityPostdoctoral fellow Ulla Gerling-Driessen, right, and her adviser, Carolyn Bertozzi, discuss their work on the NGLY1 molecule. Credit: L.A. CiceroSome of the
Oncology May 20,2024
A rare disease inspires a new way to attack cancer

A rare disease inspires a new way to attack cancer

by Nathan Collins,Stanford UniversityPostdoctoral fellow Ulla Gerling-Driessen, right, and her adviser, Carolyn Bertozzi, discuss their work on the NGLY1 molecule. Credit: L.A. CiceroSome of the
Oncology May 20,2024
Bench to beside study of a targetable enzyme controlling aggressive prostate cancer

Bench to beside study of a targetable enzyme controlling aggressive prostate cancer

by Thomas Jefferson UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Prostate cancer represents a major h
Oncology May 20,2024
Bench to beside study of a targetable enzyme controlling aggressive prostate cancer

Bench to beside study of a targetable enzyme controlling aggressive prostate cancer

by Thomas Jefferson UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Prostate cancer represents a major h
Oncology May 20,2024
An under-the-radar immune cell shows potential in fight against cancer

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin
Oncology May 20,2024
An under-the-radar immune cell shows potential in fight against cancer

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin
Oncology May 20,2024
Mechanism of a breast cancer drug points to a possible new therapy

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom
Oncology May 20,2024
Mechanism of a breast cancer drug points to a possible new therapy

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom
Oncology May 20,2024
One lung cancer drug receives NHS England approval, while another is rejected

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d
Oncology May 20,2024
One lung cancer drug receives NHS England approval, while another is rejected

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d
Oncology May 20,2024
One protein is key to the spread of lung cancer: New study finds a way to stop it

One protein is key to the spread of lung cancer: New study finds a way to stop it

by Tulane UniversityCredit: Pixabay/CC0 Public DomainA new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its
Oncology May 20,2024
One protein is key to the spread of lung cancer: New study finds a way to stop it

One protein is key to the spread of lung cancer: New study finds a way to stop it

by Tulane UniversityCredit: Pixabay/CC0 Public DomainA new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its
Oncology May 20,2024
How a common oral bacteria makes colon cancer more deadly

How a common oral bacteria makes colon cancer more deadly

by Columbia University Irving Medical CenterFusobacterium nucleatum. Credit: Baylor College of MedicineResearchers at the Columbia University College of Dental Medicine have determined howF
Oncology May 20,2024
How a common oral bacteria makes colon cancer more deadly

How a common oral bacteria makes colon cancer more deadly

by Columbia University Irving Medical CenterFusobacterium nucleatum. Credit: Baylor College of MedicineResearchers at the Columbia University College of Dental Medicine have determined howF
Oncology May 20,2024
A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno
Oncology May 20,2024
A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno
Oncology May 20,2024
Radiation after surgery triples survival for a type of pediatric brain tumor

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea
Oncology May 20,2024
Radiation after surgery triples survival for a type of pediatric brain tumor

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea
Oncology May 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com